Healthgen Biotechnology has raked in 556 million yuan ($87 million) in its pre-IPO round, while MS Energy has secured ‘tens of millions of US dollars’ in its Series B and B+ rounds.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
